Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,674 | 472 | 96.4% |
| Education | $396.69 | 6 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,749 | 134 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,230 | 54 | $0 (2024) |
| Lilly USA, LLC | $1,128 | 48 | $0 (2024) |
| UCB, Inc. | $1,118 | 42 | $0 (2024) |
| Janssen Biotech, Inc. | $947.37 | 40 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $713.82 | 22 | $0 (2024) |
| GENZYME CORPORATION | $410.59 | 11 | $0 (2022) |
| Amgen Inc. | $307.64 | 15 | $0 (2024) |
| Stemline Therapeutics Inc. | $265.88 | 4 | $0 (2021) |
| MAYNE PHARMA INC. | $263.28 | 17 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,412 | 60 | UCB, Inc. ($381.61) |
| 2023 | $1,767 | 67 | UCB, Inc. ($285.66) |
| 2022 | $1,585 | 60 | ABBVIE INC. ($663.05) |
| 2021 | $1,279 | 47 | AbbVie Inc. ($378.20) |
| 2020 | $999.16 | 45 | AbbVie Inc. ($243.31) |
| 2019 | $1,329 | 62 | AbbVie, Inc. ($376.20) |
| 2018 | $1,373 | 68 | Novartis Pharmaceuticals Corporation ($347.40) |
| 2017 | $1,327 | 69 | AbbVie, Inc. ($276.40) |
All Payment Transactions
478 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.78 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $99.89 | General |
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $43.71 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.43 | General |
| 08/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $41.93 | General |
| Category: Immunology | ||||||
| 07/29/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $19.21 | General |
| Category: DERMATOLOGY | ||||||
| 07/26/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $15.96 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Immunology | ||||||
| 07/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $47.07 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.55 | General |
| 06/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.63 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,078 | 5,203 | $612,075 | $211,087 |
| 2022 | 22 | 2,936 | 5,193 | $603,920 | $205,841 |
| 2021 | 25 | 2,692 | 4,266 | $500,994 | $192,964 |
| 2020 | 23 | 2,200 | 3,381 | $395,045 | $141,964 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,688 | 3,086 | $401,225 | $125,716 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 335 | 463 | $55,560 | $24,638 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 204 | $29,580 | $15,802 | 53.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 108 | 135 | $21,600 | $8,998 | 41.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 147 | 191 | $16,235 | $6,139 | 37.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 73 | 84 | $10,080 | $4,994 | 49.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 65 | 66 | $12,210 | $3,757 | 30.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 30 | 35 | $7,505 | $3,130 | 41.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 63 | 71 | $8,520 | $2,607 | 30.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 20 | $5,300 | $2,372 | 44.8% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 18 | 22 | $6,160 | $2,362 | 38.3% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 29 | 30 | $5,250 | $2,110 | 40.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 113 | 442 | $11,050 | $1,833 | 16.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 71 | 80 | $7,600 | $1,730 | 22.8% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 23 | 27 | $1,890 | $1,350 | 71.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 26 | 31 | $3,720 | $951.93 | 25.6% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $2,800 | $899.50 | 32.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 29 | $2,320 | $892.12 | 38.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $1,820 | $413.05 | 22.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 34 | $1,020 | $299.28 | 29.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 126 | $630.00 | $93.81 | 14.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 1,621 | 3,046 | $395,705 | $121,565 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 210 | 309 | $44,505 | $23,250 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 274 | 354 | $41,870 | $19,143 | 45.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 105 | 129 | $19,600 | $7,623 | 38.9% |
About Dr. George Sonnier, M.D
Dr. George Sonnier, M.D is a Dermatopathology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861495046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Sonnier, M.D has received a total of $11,070 in payments from pharmaceutical and medical device companies, with $1,412 received in 2024. These payments were reported across 478 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($10,674).
As a Medicare-enrolled provider, Sonnier has provided services to 10,906 Medicare beneficiaries, totaling 18,043 services with total Medicare billing of $751,855. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Dermatopathology
- Other Specialties Anatomic Pathology & Clinical Pathology, Dermatology
- Location Louisville, KY
- Active Since 05/23/2005
- Last Updated 02/19/2021
- Taxonomy Code 207ZD0900X
- Entity Type Individual
- NPI Number 1861495046
Products in Payments
- SKYRIZI (Biological) $1,166
- COSENTYX (Biological) $956.95
- TALTZ (Drug) $890.98
- Cimzia (Drug) $707.55
- TREMFYA (Drug) $663.02
- DUPIXENT (Biological) $528.82
- RINVOQ (Biological) $470.91
- Humira (Biological) $434.73
- Bimzelx (Biological) $410.61
- Otezla (Drug) $298.78
- LIBTAYO (Biological) $284.19
- ELZONRIS (Drug) $265.88
- DORYX (Drug) $263.28
- Tremfya (Drug) $262.82
- Sotyktu (Drug) $257.68
- Skyrizi (Biological) $214.29
- HUMIRA (Biological) $205.80
- COSENTYX (Drug) $180.00
- DUPIXENT (Drug) $175.35
- Enbrel (Biological) $148.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in Louisville
Dr. Stephen Smith, M.d, M.D
Dermatopathology — Payments: $9,107
Mrs. Soon Bahrami, M.d, M.D
Dermatopathology — Payments: $1,273
Mrs. Janine Malone, Md, MD
Dermatopathology — Payments: $910.25
Dr. Genevieve Wallace, Md, MD
Dermatopathology — Payments: $377.02
Dr. Steven Hodge, Md, MD
Dermatopathology — Payments: $210.30
Vilma Fabre, M.d, M.D
Dermatopathology